· Original article
Hippo insider sale: Ostergaard sells 1,169 shares
Hippo insider sale disclosures show Torben Ostergaard sold 1,169 shares on October 15, 2026, leaving him with 60,655 shares held directly.
FINANCEVELIX / News
Equities & companies · Page 252
Equities & companies
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
My news topics
My news topics →Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,001 · Page 252 / 334
· Original article
Sportradar insider sale: Miller files proposed-sale notice
Sportradar insider sale figures describe 1,840 shares, but Michael Miller’s October 15 SEC Form 144 notice does not confirm a completed transaction.
· Original article
Conduent settlement sets $80 million fund, pending approval
Conduent settlement proposes an $80 million fund over its January 2025 cyber incident, with court approval and insurance recovery still important.
· Original article
India stocks lag strong growth as earnings and rupee weaken
India stocks fell in 2026 despite strong GDP growth, as uneven corporate profits, rupee depreciation and higher oil prices complicated the outlook.
· Original article
Medtronic insider sale: Geoffrey Martha sells $4.75 million
Medtronic insider sale details show Geoffrey Martha sold 50,000 shares on October 15, 2026, with the ownership disclosure filed the next day.
· Original article
DeNA earnings: June 2025 revenue reaches ¥41.7 billion
DeNA earnings for the quarter ended June 2025 included ¥41.7 billion in revenue and ¥13.8 billion in IFRS operating profit, announced August 7, 2025.
· Original article
Seraphim results presented to retail investors on October 15
Seraphim results were presented to retail investors on October 15, 2026, but the available opening excerpt contains no financial performance figures.
· Original article
Karur Vysya earnings rise 37% in Q2 as provisions decline
Karur Vysya earnings rose 37% in Q2 FY2026–27 as interest income strengthened and provisions fell, while loan growth exceeded deposit growth.
· Original article
Avacta funding plans target cancer-drug milestones in 2027
Avacta funding plans accompany lower reported cash balances as the company advances AVA6103 toward initial efficacy data expected in the first half of 2027.
· Original article
Brytly approval gives Alcon a new OTC eye-redness treatment
Brytly approval gives Alcon a nonprescription treatment for eye redness. The FDA cleared the apraclonidine drops on October 16, 2026, for ages 12 and up.
· Original article
Medtronic insider sale: Marinaro sells $1 million in shares
Medtronic insider sale filing shows Michael Marinaro sold 10,420 shares at $96 under a trading plan adopted in March, retaining 105,916 shares.
· Original article
Williams-Sonoma insider sale: Finucane sells 794 shares
Williams-Sonoma insider sale disclosures show director Anne Finucane sold 794 shares on October 16, 2026, retaining 9,404 shares after the transaction.
Charts and market data by TradingView. Availability and delays vary by exchange.